Purple Biotech Ltd (KTOV) — Working Capital to Net Assets Ratio
Purple Biotech Ltd (KTOV) has a Working Capital to Net Assets ratio of 63.7% as of June 2020. Working capital of ILA35.78 Million (current assets of ILA65.16 Million minus current liabilities of ILA29.38 Million) is measured against net assets of ILA56.15 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See KTOV days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Purple Biotech Ltd Working Capital to Net Assets (2013–2019)
This chart shows how Purple Biotech Ltd's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2013 to 2019. As of June 2020, the ratio stands at 63.7%, reflecting working capital of ILA35.78 Million against net assets of ILA56.15 Million ILA. For the complete balance sheet picture, see KTOV current and non-current assets.
Annual Working Capital to Net Assets for Purple Biotech Ltd (2013–2019)
The table below presents the year-by-year Working Capital to Net Assets ratio for Purple Biotech Ltd from 2013 to 2019, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Purple Biotech Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 43.8% | ILA4.76 Million | ILA10.86 Million | ILA8.30 Million | ILA3.55 Million | ▼ -3.5 pp |
| 2018 | 47.3% | ILA5.20 Million | ILA11.00 Million | ILA8.51 Million | ILA3.31 Million | ▲ +0.6 pp |
| 2017 | 46.7% | ILA4.01 Million | ILA8.59 Million | ILA7.98 Million | ILA3.97 Million | ▼ -55.1 pp |
| 2016 | 101.8% | ILA13.62 Million | ILA13.38 Million | ILA14.90 Million | ILA1.27 Million | ▼ -0.1 pp |
| 2015 | 101.9% | ILA9.61 Million | ILA9.43 Million | ILA10.80 Million | ILA1.20 Million | ▲ +1.9 pp |
| 2014 | 100.0% | ILA851.00K | ILA851.00K | ILA1.76 Million | ILA908.00K | ▲ +0.0 pp |
| 2013 | 100.0% | ILA-946.00K | ILA-946.00K | ILA311.00K | ILA1.26 Million | — |